Skip to content
Trial Eligibility
Menu

Breast Cancer Clinical Trials near Ann Arbor, MI

81 studies for Breast Cancer are recruiting at 447 sites within 50 miles of Ann Arbor, Michigan, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Breast Cancer trials in the US or all trials near Ann Arbor.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Breast Cancer studies enrolling near Ann Arbor

Showing the 50 nearest of 81 studies.
  1. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    NCT05334069

    • Observational
    • Ages 40 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: Trinity Health Saint Joseph Mercy Hospital Ann Arbor (Ann Arbor, MI); Huron Gastroenterology PC (Ypsilanti, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    49 sites within 50 mi
  2. Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

    NCT05929768

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Trinity Health Saint Joseph Mercy Hospital Ann Arbor (Ann Arbor, MI); University of Michigan Comprehensive Cancer Center (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    48 sites within 50 mi
  3. Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

    NCT05879926

    • Phase 3
    • Ages 18 to 60 years
    • Sex: Female

    Nearest sites: Trinity Health Saint Joseph Mercy Hospital Ann Arbor (Ann Arbor, MI); University of Michigan Rogel Cancer Center (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    40 sites within 50 mi
  4. De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

    NCT04852887

    • Phase 3
    • Ages 50 to 70 years
    • Sex: All

    Nearest sites: Trinity Health Saint Joseph Mercy Hospital Ann Arbor (Ann Arbor, MI); University of Michigan Rogel Cancer Center (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    36 sites within 50 mi
  5. Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

    NCT06058377

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Trinity Health Saint Joseph Mercy Hospital Ann Arbor (Ann Arbor, MI); University of Michigan Rogel Cancer Center (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    34 sites within 50 mi
  6. S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

    NCT03723928

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Saint Joseph Mercy Hospital (Ann Arbor, MI); Huron Gastroenterology PC (Ypsilanti, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    32 sites within 50 mi
  7. Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

    NCT05812807

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Trinity Health Saint Joseph Mercy Hospital Ann Arbor (Ann Arbor, MI); University of Michigan Rogel Cancer Center (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    32 sites within 50 mi
  8. ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

    NCT06876714

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: University of Michigan Rogel Cancer Center (Ann Arbor, MI); Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus (Ypsilanti, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    21 sites within 50 mi
  9. Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

    NCT05564377

    • Phase 2
    • Ages Any age
    • Sex: All

    Nearest sites: Trinity Health Saint Joseph Mercy Hospital Ann Arbor (Ann Arbor, MI); University of Michigan Rogel Cancer Center (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    20 sites within 50 mi
  10. E-Mindfulness Approaches for Living After Breast Cancer

    NCT06748222

    • Phase 3
    • Ages 18 to 50 years
    • Sex: All

    Nearest sites: Trinity Health Saint Joseph Mercy Hospital Ann Arbor (Ann Arbor, MI); Henry Ford Health Providence Novi Hospital (Novi, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    13 sites within 50 mi
  11. S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

    NCT03418961

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Saint Joseph Mercy Hospital (Ann Arbor, MI); University of Michigan Comprehensive Cancer Center (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    12 sites within 50 mi
  12. Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

    NCT06393374

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: University of Michigan ( Site 0103) (Ann Arbor, MI); Henry Ford Health ( Site 0010) (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  13. A Phase 1/1b Study of IAM1363 in HER2 Cancers

    NCT06253871

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: University of Michigan (Ann Arbor, MI); Henry Ford Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  14. Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

    NCT06418204

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Trinity Health Saint Joseph Mercy Hospital Ann Arbor (Ann Arbor, MI); Trinity Health Saint Joseph Mercy Oakland Hospital (Pontiac, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  15. Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

    NCT06982521

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: University of Michigan (Ann Arbor, MI); Profound Research LLC (Royal Oak, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  16. The Cancer of the Pancreas Screening-5 CAPS5)Study

    NCT02000089

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Michigan (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    NCT03452774

    • Observational
    • Ages Any age
    • Sex: All

    Nearest site: Massive Bio SYNERGY-AI site (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer

    NCT05183126

    • Phase 4
    • Ages 18 years and older
    • Sex: Female

    Nearest site: University of Michigan Rogel Cancer Center (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

    NCT05216432

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Michigan (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial

    NCT05379153

    • Phase 3
    • Ages 22 years and older
    • Sex: Female

    Nearest site: Trinity Health IHA - Obstetrics and Gynecology West Arbor (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer

    NCT05467891

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Michigan Health System (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

    NCT05768932

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Michigan (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

    NCT05902988

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Michigan (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

    NCT05941507

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Michigan (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. Breast Cancer Resiliency Through Exercise Program (B-REP)

    NCT06100263

    • Interventional
    • Ages 18 years and older
    • Sex: Female

    Nearest site: University of Michigan (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

    NCT06184750

    • Phase 2
    • Ages 18 to 55 years
    • Sex: Female

    Nearest site: University of Michigan Rogel Cancer Center (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  27. Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

    NCT06195306

    • Phase 2
    • Ages 45 to 74 years
    • Sex: Female
    • Accepts healthy volunteers

    Nearest site: University of Michigan Rogel Cancer Center (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  28. A Study of PHST001 in Advanced Solid Tumors

    NCT06840886

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Michigan Rogel Cancer Center (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  29. CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer

    NCT06915168

    • Interventional
    • Ages Any age
    • Sex: All

    Nearest site: University of Michigan Comprehensive Cancer Center (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  30. ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

    NCT07007559

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Michigan Rogel Cancer Center (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  31. Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

    NCT07085767

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Clinical Trial Site (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  32. Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial

    NCT07158021

    • Phase 2
    • Ages 18 years and older
    • Sex: Female

    Nearest site: University of Michigan Comprehensive Cancer Center (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  33. Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

    NCT07211178

    • Observational
    • Ages 18 to 99 years
    • Sex: All

    Nearest site: Trinity Health (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  34. A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients

    NCT07291414

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Michigan Comprehensive Cancer Center (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  35. A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS Trial

    NCT07443943

    • Phase 2
    • Ages Any age
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: University of Michigan Rogel Cancer Center (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  36. Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

    NCT07391774

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus (Ypsilanti, MI); Trinity Health IHA Medical Group Hematology Oncology - Canton (Canton, MI)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    13 sites within 50 mi
  37. Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer

    NCT05455619

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Trinity Health (Ypsilanti, MI)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  38. CtDNA Based MRD Testing for NAC Monitoring in TNBC

    NCT06230185

    • Observational
    • Ages 18 years and older
    • Sex: Female

    Nearest site: Trinity Health-Michigan (Ypsilanti, MI)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  39. The Vanguard Study: Testing a New Way to Screen for Cancer

    NCT06995898

    • Interventional
    • Ages 45 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: Henry Ford Medical Center - Plymouth (Plymouth, MI); Henry Ford Medical Center-Columbus (Novi, MI)

    Distance to nearest recruiting site
    ~15 mi (city-level)
    Recruiting sites
    13 sites within 50 mi
  40. A Study of the TheraBionic P1 Device in Breast Cancer

    NCT07218432

    • Interventional
    • Ages 22 years and older
    • Sex: Female

    Nearest sites: Karmanos Cancer Institute Weisberg Cancer Treatment Center (Farmington Hills, MI); Karmanos Cancer Institute at McLaren Clarkston (Clarkston, MI)

    Distance to nearest recruiting site
    ~24 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  41. A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

    NCT05208762

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Karmanos Cancer Institute (Farmington Hills, MI); Karmanos Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    ~24 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  42. Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

    NCT06500481

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Weisberg Cancer Treatment Center (Farmington Hills, MI); Wayne State University/Karmanos Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    ~24 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  43. A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors

    NCT06956690

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Research Site (Farmington Hills, MI)

    Distance to nearest recruiting site
    ~24 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  44. MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

    NCT03053193

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Beaumont Breast Care Center (Royal Oak, MI); Comprehensive Breast Care (Troy, MI)

    Distance to nearest recruiting site
    ~34 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  45. The PREDICT Registry:

    NCT03448926

    • Observational
    • Ages 30 to 85 years
    • Sex: Female

    Nearest sites: Corewell Health William Beaumont University Center (Royal Oak, MI); Comprehensive Breast Care (Troy, MI)

    Distance to nearest recruiting site
    ~34 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  46. ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

    NCT07173751

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Profound Research LLC at Michigan Hematology and Oncology Consultants (Royal Oak, MI); Karmanos Cancer Center (Detroit, MI)

    Distance to nearest recruiting site
    ~34 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  47. Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

    NCT05633654

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: William Beaumont Hospital (Royal Oak, MI)

    Distance to nearest recruiting site
    ~34 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  48. Quantitative MRI Assessment of Breast Cancer Therapy Response

    NCT05704062

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: Corewell Health William Beaumont University Hospital (Royal Oak, MI)

    Distance to nearest recruiting site
    ~34 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  49. Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

    NCT06380751

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Research Site (Royal Oak, MI)

    Distance to nearest recruiting site
    ~34 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  50. A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

    NCT07310420

    • Phase 1
    • Ages 18 to 55 years
    • Sex: Female

    Nearest site: Profound Research LLC at Michigan Hematology and Oncology Consultants (Royal Oak, MI)

    Distance to nearest recruiting site
    ~34 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Breast Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.